Paul Ruff

24.3k citations
163 papers · 9.2k · 3 hit papers · h-index 33

Impact in

  • Oncology top 0.2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Viral-associated cancers and disorders
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 34
    • Viral-associated cancers and disorders 25
    • Global Cancer Incidence and Screening 13
    • Cancer Immunotherapy and Biomarkers 7
    • Cancer Treatment and Pharmacology 7
    • Lung Cancer Treatments and Mutations 14

Paul Ruff

152 papers receiving 8.9k citations

Paul Ruff's Hit Papers

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen 2012 · 1.0k citations
1.0k0+5+11Years since publication10002.0k3.0k

Peers

Paul Ruff
Comparison fields: 5 of 142
  • Oncology 5.5k
  • Hepatology 1.3k
  • Cancer Research 1.0k
  • Pathology and Forensic Medicine 1.2k
  • Pulmonary and Respiratory Medicine 1.8k
Replace Bert H. O’Neil with:
Bert H. O’Neil United States
David Khayat France
Sandro Pignata Italy
Tim Maughan United Kingdom
Dongyun Yang United States
Chiun Hsu Taiwan
Nicola Silvestris Italy
Eduardo Díaz‐Rubio Spain
Miriam Koopman Netherlands
Per Pfeiffer Denmark
Paul Ruff relative to Bert H. O’Neil United States Bert H. O’Neil's profile →
Citations per field
00.5×1.5×
Bert H. O’Neil · 1×
Citations per year

Countries citing papers authored by Paul Ruff

Since Specialization
Citations

This map shows the geographic impact of Paul Ruff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Ruff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Ruff more than expected).

Fields of papers citing papers by Paul Ruff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Ruff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Ruff. The network helps show where Paul Ruff may publish in the future.

Co-authors

The 25 scholars most cited alongside Paul Ruff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Ruff Line = papers co-authored together Paul Ruff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 163 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Hit paper breakdown →
20093017
2
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study
Hit paper breakdown →
20101393
3
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Hit paper breakdown →
20121039
4 2014354
5 1999223
6 2007213
7 2013167
8 1990146
9 2000140
10 1991134
11 2008128
12 1997115
13 200795
14 198793
15 199980
16 200974
17 201871
18 199765
19 199360
20 201654

About Paul Ruff

Paul Ruff is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Epidemiology and Pathology and Forensic Medicine, having authored 163 papers that have together received 9.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (34 papers), Viral-associated cancers and disorders (25 papers), Cancer Genomics and Diagnostics (14 papers), Lung Cancer Treatments and Mutations (14 papers), Global Cancer Incidence and Screening (13 papers), Cancer Immunotherapy and Biomarkers (7 papers), Cancer Treatment and Pharmacology (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (5.5k citations), Hepatology (1.3k citations), Cancer Research (1.0k citations), Pathology and Forensic Medicine (1.2k citations) and Pulmonary and Respiratory Medicine (1.8k citations). Paul Ruff has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Eric Van Cutsem, G. Bodoky, J. Załuski, Johannes Nippgen, Philippe Rougier, Erika Hitre, Tamás Pintér, Claus-Henning Köhne, Gunnar Folprecht and Jae Kyung Roh. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, The Oncologist and JCO Global Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact